Dr Chris Jones’ team investigates ways to translate basic molecular pathology findings into improved clinical outcomes for children with cancer.
Chris Jones is the Interim Head of Division for Molecular Pathology and heads the Glioma Team whose research aims to find the genes which drive the development of childhood brain tumours. He is Professor of Childhood Brain Tumour Biology, and Preclinical Chair of the international CONNECT consortium.